Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1C | Q13936 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | FAP | Q12884 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.33 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22844515 | 1.00 | CACNA1C (0.41) | CACNA1CKDM4ETSHRHSD17B10TDP1 | |
| SCHEMBL14470898 | 0.87 | CACNA1C (0.42) | CACNA1CKDM4EPTGS1ESR1PDE4A | |
| SCHEMBL25607747 | 0.86 | FAP (0.36) | CACNA1CKDM4ETSHRHSD17B10TDP1 | |
| SCHEMBL22844517 | 0.86 | FAP (0.36) | CACNA1CKDM4ETSHRHSD17B10TDP1 | |
| SCHEMBL25601319 | 0.85 | ELANE (0.47) | ELANE | |
| SCHEMBL29875193 | 0.85 | CACNA1C (0.40) | CACNA1CKDM4EPTGS1ESR1PDE4A | |
| SCHEMBL23258102 | 0.84 | FAP (0.33) | CACNA1CKDM4ETSHRHSD17B10TDP1 | |
| SCHEMBL8184773 | 0.83 | CACNA1C (0.44) | CACNA1CKDM4EPTGS1ESR1PDE4A | |
| SCHEMBL13946281 | 0.83 | CACNA1C (0.44) | CACNA1CKDM4EPTGS1ESR1PDE4A | |
| SCHEMBL21556160 | 0.82 | CACNA1C (0.39) | CACNA1CKDM4EPTGS1ESR1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173079-A1 | Conjugate Molecules | DIVERSE BIOTECH, INC. (US) | 2023-06-08 | — | — | US | disclosed |
| US-20230173079-A1 | Conjugate Molecules | DIVERSE BIOTECH, INC. (US) | 2023-06-08 | — | — | US | disclosed |
| CN-114957258-A | Synthesis of wide-spectrum serine beta-lactamase inhibitor based on carbapenem structure and application of inhibitor in drug-resistant bacteria inhibition | 华东理工大学 | 2022-08-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173079-A1 | Conjugate Molecules | CNR2, CNR1, MAG | CACNA1C 4432/4885KDM4E 1418/4885TSHR 3475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.